Showing results (231-240 of 1,294) with videos related to

Sort By:
Pageof 130
Respiratory Investigation|July 4, 2012
Case of interstitial lung disease with anti-EJ and anti-CCP antibodies preceding rheumatoid arthritisHiromi Tomioka, Masahiro Kaneko, Yoshinori Kogata, et al.
Respiratory Investigation|February 26, 2022
Predictive role of CYFRA 21-1 for S-1 monotherapy in non-small cell lung cancer patientsYusuke Kagawa, Kazuki Sone, Tetsuya Oguri, et al.
Respiratory Investigation|September 29, 2021
Fractal dimension in CT low attenuation areas is predictive of long-term oxygen therapy initiation in COPD patients: Results from two observational cohort studiesTakahiro Ibaraki, Koich Tomoda, Nobuhiro Fujioka, et al.
Respiratory Investigation|October 4, 2021
2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue diseaseYasuhiro Kondoh, Shigeki Makino, Takashi Ogura, et al.
Respiratory Investigation|September 27, 2021
Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first-third waves with the fourth waveYu Kurahara, Takehiko Kobayashi, Sayoko Shintani, et al.
Respiratory Investigation|May 12, 2023
A retrospective study of crossover ambulatory oxygen walk testing in patients with fibrotic lung diseaseManjit K Cartlidge, Hazel Wilkie, Feng Li, et al.
Respiratory Investigation|May 14, 2023
Peripheral transbronchial needle aspiration-guided pinpoint cryobiopsy of lung nodule without bronchus sign: A case reportSze Shyang Kho, Larry Ellee Nyanti, Chan Sin Chai, et al.
Respiratory Investigation|April 30, 2023
Assessment of changes in the epidemiology and prognosis of non-SARS-CoV-2 respiratory infections one year after recovery from COVID-19Ahmad Z Al Meslamani, Nour Sammani
Respiratory Investigation|April 30, 2023
Use of the neutrophil-to-lymphocyte ratio and an oxygen requirement to predict disease severity in patients with COVID-19Takuya Ozawa, Takanori Asakura, Shotaro Chubachi, et al.
Respiratory Investigation|April 29, 2023
Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in JapanYasutaka Hirasawa, Jiro Terada, Yu Shionoya, et al.
Pageof 130